Metagenomi Therapeutics, Inc. (NASDAQ:MGX) Analysts Are Cutting Their Estimates: Here's What You Need To Know
Analysts have significantly cut their revenue estimates and increased loss per share forecasts for Metagenomi Therapeutics, Inc. (NASDAQ:MGX) following the company's recent quarterly results. Revenues were 107% lower than predicted, and earnings fell short, leading to a 13% drop in the average price target …